Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcription quantitative polymerase chain reaction

Res Vet Sci. 2004 Dec;77(3):223-9. doi: 10.1016/j.rvsc.2004.03.001.

Abstract

MDR-1 gene product mediated multidrug resistance is thought to play a major role in the outcome of chemotherapy in some canine tumors, especially malignant lymphoma. In the present study, MDR-1 RNA expression in normal lymph node and liver tissue as well as in tumor biopsies from 23 dogs with lymphomas and two dogs with liver tumors was measured by real-time RT-quantitative PCR. MDR-1 gene expression was detected in all samples analyzed. Comparably high MDR-1 RNA levels were measured in all normal liver tissues, one of the lymphomas and a cholangiocarcinoma. MDR-1 expression levels in canine lymphomas were found to vary over a wide range with most tumors expressing relative low levels. Interestingly, gastrointestinal lymphomas expressed higher MDR-1 RNA levels than multicentric lymphomas (p = 0.03). In conclusion, real-time RT-quantitative PCR appears to be a suitable method for sensitive and quantitative determination of MDR-1 gene expression in canine normal and neoplastic tissues.

MeSH terms

  • Animals
  • Dog Diseases / metabolism*
  • Dogs
  • Female
  • Gene Expression
  • Gene Expression Regulation, Neoplastic*
  • Genes, MDR / genetics*
  • Liver / metabolism*
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / veterinary*
  • Lymph Nodes / metabolism*
  • Lymphoma / metabolism
  • Lymphoma / veterinary*
  • Male
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Reverse Transcriptase Polymerase Chain Reaction / veterinary

Substances

  • RNA, Messenger